Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: Inhibition of tumor angiogenesis with extensive tumor necrosis

This publication has 31 references indexed in Scilit:

• Combination chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiforme
  Journal of Neuro-Oncology, 2005
• Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398
  Journal of Gastroenterology and Hepatology, 2004
• Differential Effects of Selective COX-2 Inhibitors on Cell Cycle Regulation and Proliferation of Glioblastoma Cell Lines
  Cancer Biology & Therapy, 2004
• COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression
  Proceedings of the National Academy of Sciences, 2002
• A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas
  Neuro-Oncology, 2002
• Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse
  Seminars in Radiation Oncology, 2001
• Cyclooxygenase-2: a novel target for cancer chemotherapy?
  Zeitschrift für Krebsforschung und Klinische Onkologie, 2001
• Disruption of cyclooxygenase-1 gene results in an impaired response to radiation injury
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2000
• Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Cyclooxygenase in biology and disease
  The FASEB Journal, 1998